Xtant Medical Holdings (STU:XMS) Days Sales Outstanding : 68.99 (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Xtant Medical Holdings Days Sales Outstanding?

Xtant Medical Holdings's average Accounts Receivable for the three months ended in Mar. 2024 was €19.39 Mil. Xtant Medical Holdings's Revenue for the three months ended in Mar. 2024 was €25.64 Mil. Hence, Xtant Medical Holdings's Days Sales Outstanding for the three months ended in Mar. 2024 was 68.99.

The historical rank and industry rank for Xtant Medical Holdings's Days Sales Outstanding or its related term are showing as below:

STU:XMS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.35 Med: 57.79 Max: 70.04
Current: 62.75

During the past 13 years, Xtant Medical Holdings's highest Days Sales Outstanding was 70.04. The lowest was 46.35. And the median was 57.79.

STU:XMS's Days Sales Outstanding is ranked better than
52.09% of 812 companies
in the Medical Devices & Instruments industry
Industry Median: 65.015 vs STU:XMS: 62.75

Xtant Medical Holdings's Days Sales Outstanding increased from Mar. 2023 (58.15) to Mar. 2024 (68.99).

Xtant Medical Holdings Days Sales Outstanding Historical Data

The historical data trend for Xtant Medical Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xtant Medical Holdings Days Sales Outstanding Chart

Xtant Medical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

56.09

61.47

44.73

55.28

63.77

Xtant Medical Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															58.15	58.15	59.61	65.41	68.99

Competitive Comparison of Xtant Medical Holdings's Days Sales Outstanding

For the Medical Devices subindustry, Xtant Medical Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xtant Medical Holdings's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Xtant Medical Holdings's Days Sales Outstanding falls into.

Xtant Medical Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Xtant Medical Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (10.245	+	19.01)	/	2 )	/	83.725	*	365
=	14.6275					/	83.725	*	365
=	63.77

Xtant Medical Holdings's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (19.01	+	19.765)	/	2 )	/	25.643	*	365 / 4
=	19.3875					/	25.643	*	365 / 4
=	68.99

Xtant Medical Holdings (STU:XMS) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Xtant Medical Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Xtant Medical Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Xtant Medical Holdings (STU:XMS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xtant Medical Holdings Inc (STU:XMS) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

XTNT:USA

Address

664 Cruiser Lane, Belgrade, MT, USA, 59714

Website

http://www.xtantmedical.com

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.

Xtant Medical Holdings (STU:XMS) Headlines

No Headlines